81
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Augmentation of hepatocellular carcinoma malignancy by annexin A5 through modulation of invasion and angiogenesis

, , , , , & show all
Pages 939-953 | Received 15 Mar 2024, Accepted 05 May 2024, Published online: 14 May 2024

References

  • Zou H, Li M, Lei Q, et al. Economic burden and quality of life of hepatocellular carcinoma in greater China: a systematic review. Front Public Health. 2022;10:801981. doi: 10.3389/fpubh.2022.801981.
  • Estes C, Anstee QM, Arias-Loste MT, et al. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030. J Hepatol. 2018;69(4):896–904. doi: 10.1016/j.jhep.2018.05.036.
  • Xu X-F, Xing H, Han J, et al. Risk factors, patterns, and outcomes of late recurrence after liver resection for hepatocellular carcinoma: a multicenter study from China. JAMA Surg. 2019;154(3):209–217. doi: 10.1001/jamasurg.2018.4334.
  • Luo P, Yin P, Hua R, et al. A large-scale, multicenter serum metabolite biomarker identification study for the early detection of hepatocellular carcinoma. Hepatology. 2018;67(2):662–675. doi: 10.1002/hep.29561.
  • Lin D-C, Mayakonda A, Dinh HQ, et al. Genomic and epigenomic heterogeneity of hepatocellular carcinoma. Cancer Res. 2017;77(9):2255–2265. doi: 10.1158/0008-5472.CAN-16-2822.
  • Craig AJ, von Felden J, Garcia-Lezana T, et al. Tumour evolution in hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2020;17(3):139–152. doi: 10.1038/s41575-019-0229-4.
  • Zheng H, Pomyen Y, Hernandez MO, et al. Single-cell analysis reveals cancer stem cell heterogeneity in hepatocellular carcinoma. Hepatology. 2018;68(1):127–140. doi: 10.1002/hep.29778.
  • Peng B, Guo C, Guan H, et al. Annexin A5 as a potential marker in tumors. Clin Chim Acta. 2014;427:42–48. doi: 10.1016/j.cca.2013.09.048.
  • Lee SE, Lee CM, Won JE, et al. Enhancement of anticancer immunity by immunomodulation of apoptotic tumor cells using annexin A5 protein-labeled nanocarrier system. Biomaterials. 2022;288:121677. doi: 10.1016/j.biomaterials.2022.121677.
  • Peng L, Yang W, Deng X, et al. Research progress on ANXA5 in recurrent pregnancy loss. J Reprod Immunol. 2022;153:103679. doi: 10.1016/j.jri.2022.103679.
  • Woodward A, Faria GNF, Harrison RG. Annexin A5 as a targeting agent for cancer treatment. Cancer Lett. 2022;547:215857. doi: 10.1016/j.canlet.2022.215857.
  • Zhou J, Chang M, Li J, et al. Knockdown of annexin A5 restores gefitinib sensitivity by promoting G2/M cell cycle arrest. Respir Res. 2018;19(1):96. doi: 10.1186/s12931-018-0804-1.
  • Wang X, Dai Y, Zhang J, et al. Annexin A5 suppression promotes the progression of cervical cancer. Arch Gynecol Obstet. 2023;307(3):937–943. doi: 10.1007/s00404-022-06524-1.
  • Sun C-B, Zhao A-Y, Ji S, et al. Expression of annexin A5 in serum and tumor tissue of patients with Colon cancer and its clinical significance. World J Gastroenterol. 2017;23(39):7168–7173. doi: 10.3748/wjg.v23.i39.7168.
  • Tang J, Qin Z, Han P, et al. High annexin A5 expression promotes tumor progression and poor prognosis in renal cell carcinoma. Int J Oncol. 2017;50(5):1839–1847. doi: 10.3892/ijo.2017.3942.
  • Li L, Zou J, Dai Y, et al. Burst release of encapsulated annexin A5 in tumours boosts cytotoxic T-cell responses by blocking the phagocytosis of apoptotic cells. Nat Biomed Eng. 2020;4(11):1102–1116. doi: 10.1038/s41551-020-0599-5.
  • Shin D-W, Kwon Y-J, Ye D-J, et al. Auranofin suppresses plasminogen activator inhibitor-2 expression through annexin A5 induction in human prostate cancer cells. Biomol Ther (Seoul). 2017;25(2):177–185. doi: 10.4062/biomolther.2016.223.
  • Guo W-X, et al. [Proteomic analysis on portal vein tumor thrombus-associated proteins for hepatocellular carcinoma. ]. Zhonghua Yi Xue Za Zhi. 2007;87(30):2094–2097.
  • Hein T, Krammer PH, Weyd H. Molecular analysis of annexin expression in cancer. BMC Cancer. 2022;22(1):994. doi: 10.1186/s12885-022-10075-8.
  • Julich-Haertel H, Urban SK, Krawczyk M, et al. Cancer-associated circulating large extracellular vesicles in cholangiocarcinoma and hepatocellular carcinoma. J Hepatol. 2017;67(2):282–292. doi: 10.1016/j.jhep.2017.02.024.
  • Sun X, Wei B, Liu S, et al. Anxa5 mediates the in vitro malignant behaviours of murine hepatocarcinoma Hca-F cells with high lymph node metastasis potential preferentially via ERK2/p-ERK2/c-Jun/p-c-Jun(Ser73) and E-cadherin. Biomed Pharmacother. 2016;84:645–654. doi: 10.1016/j.biopha.2016.09.086.
  • Sun X, Liu S, Wang J, et al. Annexin A5 regulates hepatocarcinoma malignancy via CRKI/II-DOCK180-RAC1 integrin and MEK-ERK pathways. Cell Death Dis. 2018;9(6):637. doi: 10.1038/s41419-018-0685-8.
  • Herrera-López EE, Guerrero-Escalera D, Aguirre-Maldonado I, et al. Annexins A2 and A5 are potential early biomarkers of hepatocarcinogenesis. Sci Rep. 2023;13(1):6948. doi: 10.1038/s41598-023-34117-8.
  • Linde MH, Fan AC, Köhnke T, et al. Reprogramming cancer into Antigen-Presenting cells as a novel immunotherapy. Cancer Discov. 2023;13(5):1164–1185. doi: 10.1158/2159-8290.CD-21-0502.
  • Ren B, Yang J, Wang C, et al. High-resolution Hi-C maps highlight multiscale 3D epigenome reprogramming during pancreatic cancer metastasis. J Hematol Oncol. 2021;14(1):120. doi: 10.1186/s13045-021-01131-0.
  • Vallabhapurapu SD, Blanco VM, Sulaiman MK, et al. Variation in human cancer cell external phosphatidylserine is regulated by flippase activity and intracellular calcium. Oncotarget. 2015;6(33):34375–34388. doi: 10.18632/oncotarget.6045.
  • Zhang X, Huo L, Jin H, et al. Anti-cancer activity of annexin V in murine melanoma model by suppressing tumor angiogenesis. Oncotarget. 2017;8(26):42602–42612. doi: 10.18632/oncotarget.16645.
  • Gross J, Palmowski K, Doleschel D, et al. Change of apoptosis and glucose metabolism in lung cancer xenografts during cytotoxic and anti-angiogenic therapy assessed by annexin V based optical imaging and 18F-FDG-PET/CT. Contrast Media & Molecular Imaging. 2021;2021:1–11. doi: 10.1155/2021/6676337.
  • Kazmierczak PM, Burian E, Eschbach R, et al. Monitoring cell death in Regorafenib-Treated experimental Colon carcinomas using Annexin-Based optical fluorescence imaging validated by perfusion MRI. PLoS One. 2015;10(9):e0138452. doi: 10.1371/journal.pone.0138452.
  • Kang TH, Park JH, Yang A, et al. Annexin A5 as an immune checkpoint inhibitor and tumor-homing molecule for cancer treatment. Nat Commun. 2020;11(1):1137. doi: 10.1038/s41467-020-14821-z.
  • Wang S, Wang Y, Xun X, et al. Hedgehog signaling promotes sorafenib resistance in hepatocellular carcinoma patient-derived organoids. J Exp Clin Cancer Res. 2020;39(1):22. doi: 10.1186/s13046-020-1523-2.
  • Kutner RH, Zhang X-Y, Reiser J. Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors. Nat Protoc. 2009;4(4):495–505. doi: 10.1038/nprot.2009.22.
  • Wang X, Xu B-L, Chen X-W. Acute gene inactivation in the adult mouse liver using the CRISPR-Cas9 technology. STAR Protoc. 2021;2(3):100611. doi: 10.1016/j.xpro.2021.100611.
  • S, M, et al. Activation of concurrent apoptosis and necroptosis by SMAC mimetics for the treatment of refractory and relapsed ALL. Sci Transl Med. 2016;8(339):339–ra370.
  • Jiang W, Hua R, Wei M, et al. An optimized method for high-titer lentivirus preparations without ultracentrifugation. Sci Rep. 2015;5(1):13875. doi: 10.1038/srep13875.
  • Li Y, Cheng Q, Gao J, et al. WWP1 upregulation predicts poor prognosis and promotes tumor progression by regulating ubiquitination of NDFIP1 in intrahepatic cholangiocarcinoma. Cell Death Discov. 2022;8(1):107. doi: 10.1038/s41420-022-00882-0.
  • Li Y, Xia Y, Jiang T, et al. Long noncoding RNA DIAPH2-AS1 promotes neural invasion of gastric cancer via stabilizing NSUN2 to enhance the m5C modification of NTN1. Cell Death Dis. 2023;14(4):260. doi: 10.1038/s41419-023-05781-5.
  • Wang X, Yang L, Wang Y-C, et al. Comparative analysis of cell lineage differentiation during hepatogenesis in humans and mice at the single-cell transcriptome level. Cell Res. 2020;30(12):1109–1126. doi: 10.1038/s41422-020-0378-6.
  • Arnaoutova I, Kleinman HK. In vitro angiogenesis: endothelial cell tube formation on gelled basement membrane extract. Nat Protoc. 2010;5(4):628–635. doi: 10.1038/nprot.2010.6.
  • Niu M, Yi M, Wu Y, et al. Synergistic efficacy of simultaneous anti-TGF-β/VEGF bispecific antibody and PD-1 blockade in cancer therapy. J Hematol Oncol. 2023;16(1):94. doi: 10.1186/s13045-023-01487-5.
  • Hagemann-Jensen M, Ziegenhain C, Sandberg R. Scalable single-cell RNA sequencing from full transcripts with smart-seq3xpress. Nat Biotechnol. 2022;40(10):1452–1457. doi: 10.1038/s41587-022-01311-4.
  • Andrews S. FastQC: A quality control tool for high throughput sequence data. 2010; Available from: http://www.bioinformatics.babraham.ac.uk/projects/fastqc/.
  • Patel RK, Jain M. NGS QC toolkit: a toolkit for quality control of next generation sequencing data. PLoS One. 2012;7(2):e30619. doi: 10.1371/journal.pone.0030619.
  • Kim D, Paggi JM, Park C, et al. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat Biotechnol. 2019;37(8):907–915. doi: 10.1038/s41587-019-0201-4.
  • Pertea M, Pertea GM, Antonescu CM, et al. StringTie enables improved reconstruction of a transcriptome from RNA-seq reads. Nat Biotechnol. 2015;33(3):290–295. doi: 10.1038/nbt.3122.
  • Anders S, Huber W. Differential expression analysis for sequence count data. Genome Biol. 2010;11(10):R106. doi: 10.1186/gb-2010-11-10-r106.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.